These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 15677486

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Mutational analysis implicates the amyloid fibril as the toxic entity in Huntington's disease.
    Drombosky KW, Rode S, Kodali R, Jacob TC, Palladino MJ, Wetzel R.
    Neurobiol Dis; 2018 Dec; 120():126-138. PubMed ID: 30171891
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Increased energy metabolism rescues glia-induced pathology in a Drosophila model of Huntington's disease.
    Besson MT, Dupont P, Fridell YW, Liévens JC.
    Hum Mol Genet; 2010 Sep 01; 19(17):3372-82. PubMed ID: 20566711
    [Abstract] [Full Text] [Related]

  • 56. Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy.
    Minamiyama M, Katsuno M, Adachi H, Waza M, Sang C, Kobayashi Y, Tanaka F, Doyu M, Inukai A, Sobue G.
    Hum Mol Genet; 2004 Jun 01; 13(11):1183-92. PubMed ID: 15102712
    [Abstract] [Full Text] [Related]

  • 57. Inhibitors of metabolism rescue cell death in Huntington's disease models.
    Varma H, Cheng R, Voisine C, Hart AC, Stockwell BR.
    Proc Natl Acad Sci U S A; 2007 Sep 04; 104(36):14525-30. PubMed ID: 17726098
    [Abstract] [Full Text] [Related]

  • 58. Synergistic Toxicity of Polyglutamine-Expanded TATA-Binding Protein in Glia and Neuronal Cells: Therapeutic Implications for Spinocerebellar Ataxia 17.
    Yang Y, Yang S, Guo J, Cui Y, Tang B, Li XJ, Li S.
    J Neurosci; 2017 Sep 20; 37(38):9101-9115. PubMed ID: 28821675
    [Abstract] [Full Text] [Related]

  • 59. Sodium dodecyl sulfate-insoluble oligomers are involved in polyglutamine degeneration.
    Wong SL, Chan WM, Chan HY.
    FASEB J; 2008 Sep 20; 22(9):3348-57. PubMed ID: 18559990
    [Abstract] [Full Text] [Related]

  • 60. A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neurodegeneration in vivo.
    Zhang X, Smith DL, Meriin AB, Engemann S, Russel DE, Roark M, Washington SL, Maxwell MM, Marsh JL, Thompson LM, Wanker EE, Young AB, Housman DE, Bates GP, Sherman MY, Kazantsev AG.
    Proc Natl Acad Sci U S A; 2005 Jan 18; 102(3):892-7. PubMed ID: 15642944
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.